CTOs on the Move

ZOLL

www.zoll.com

 
ZOLL Medical Corporation, an Asahi Kasei Group company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims in need of resuscitation and critical care. We are looking for strong candidates who take initiative to continuously improve what they do in an effort to meet our customers` needs. We offer the challenge ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $100-250 Million
  • www.zoll.com
  • 269 Mill Road
    Chelmsford, MA USA 01824
  • Phone: 978.421.9655

Executives

Name Title Contact Details
Justin Barron
 Director of IT Operations / Information Security Officer Profile
Jonathan Turner
 VP, Compliance, Privacy and Governance Profile
Tim Williams
 Director, Information Security and Cyber Risk Profile

Similar Companies

DMG America

DMG America is a Englewood, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Respicardia

Founded in 2006 and headquartered near Minneapolis, Minnesota, Respicardia® is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve Respiratory Rhythm Management and cardiovascular health. The remedē® System is an innovative implantable stimulation device designed to restore natural breathing during sleep for patients with Central Sleep Apnea.

Card Group

Card Group is a Deer Park, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ViewRay

ViewRay Incorporated is a Bedford, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cytori

Cytori Therapeutics is dedicated to developing and delivering innovative cell-based therapies to improve the quality and length of life. We are a global, public company engaged in the development and commercialization of stem and regenerative cell therapies for the treatment of cardiovascular disease, reconstructive surgery and other serious, chronic, and life threatening conditions.